Skba Capital Management LLC Pfizer Inc Transaction History

Skba Capital Management LLC

$642 Million
Q3 2024

A detailed history of Skba Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Skba Capital Management LLC holds 428,850 shares of PFE stock, worth $11.3 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares

428,850

Previous 411,850 4.13%

Holding current value

$11.3 Million

Previous $11.5 Million 7.7%

% of portfolio

1.93%

Previous 1.92%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $470,900 - $533,630	17,000 Added 4.13%	428,850 $12.4 Million
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $2.47 Million - $2.89 Million	97,750 Added 31.12%	411,850 $11.5 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $504,855 - $579,735	19,500 Added 6.62%	314,100 $8.72 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $7.7 Million - $10 Million	294,600 New	294,600 $8.48 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $150,972 - $184,299	-3,450 Reduced 33.01%	7,000 $306,000
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $32,025 - $39,683	-700 Reduced 6.28%	10,450 $541,000
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $86,772 - $128,625	-2,100 Reduced 15.85%	11,150 $658,000
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $3,925 - $5,042	100 Added 0.76%	13,250 $570,000
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $73,615 - $83,394	2,050 Added 18.47%	13,150 $515,000
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $38,513 - $43,435	-1,150 Reduced 9.39%	11,100 $402,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $192,452 - $244,720	5,750 Added 88.46%	12,250 $451,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $206,375 - $242,125	6,500 New	6,500 $239,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skba Capital Management LLC with notifications on news.

Account

Skba Capital Management LLC Pfizer Inc Transaction History